Literature DB >> 25475810

Urological outcome in patients with Currarino syndrome.

Luca Pio1, Gianluca Piatelli2, Andrea Rossi2, Pierluigi Scarsi2, Elisa Merello2, Valeria Capra2, Armando Cama2, Piero Buffa2, Michele Torre2.   

Abstract

INTRODUCTION: Currarino syndrome is a type of caudal regression syndrome characterized by the association of hemisacrum, anorectal malformation and presacral mass. Only few studies on small series report the incidence of urinary dysfunction in Currarino syndrome. Our aim was to evaluate the urological outcome in patients with Currarino syndrome. PATIENTS AND METHODS: We retrospectively reviewed all Currarino syndrome patients treated in our institution. Of 20 patients, we could evaluate the urological outcome in 16. This group of patients underwent clinical, radiological and urodynamic evaluation.
RESULTS: All 16 patients had a sacral defect, fourteen of them presenting a presacral mass (87.5%), eight a tethered cord (50%), and 7 anorectal malformations (43.7%). Eight patients underwent neurosurgical treatment for neural tube defects. In 14 patients, the presacral mass was resected. One case presented detrusor overactivity, 2 recurrent urinary tract infections and 2 vesicoureteral refluxes. Both patients with lipomyeloschisis had a neuropathic bladder. All the other patients could void the bladder spontaneously. Renal function was normal in all.
CONCLUSION: Currarino syndrome is a rare congenital disorder presenting a variable phenotype. Urological outcome is good in the majority of patients.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Currarino syndrome; Neuropathic bladder; Urological outcome

Mesh:

Year:  2014        PMID: 25475810     DOI: 10.1016/j.jpedsurg.2014.05.038

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  1 in total

1.  Currarino syndrome and microcephaly due to a rare 7q36.2 microdeletion: a case report.

Authors:  Lucia Cococcioni; Susanna Paccagnini; Elena Pozzi; Luigina Spaccini; Elisa Cattaneo; Serena Redaelli; Francesca Crosti; Gian Vincenzo Zuccotti
Journal:  Ital J Pediatr       Date:  2018-05-25       Impact factor: 2.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.